Caitriona Kelly, Maria McEnery, Selene Daly, Anne Marie Tobin, Triona McCarthy
{"title":"Assessment of sun protection factors in the Irish adult population following the SunSmart Campaign 2023.","authors":"Caitriona Kelly, Maria McEnery, Selene Daly, Anne Marie Tobin, Triona McCarthy","doi":"10.1093/ced/llae450","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>SunSmart is the National Cancer Control Programme's annual skin cancer prevention awareness campaign.</p><p><strong>Objectives: </strong>This study aimed to assess sun protection attitudes following the 2023 campaign, and compare findings to 2022.</p><p><strong>Methods: </strong>An online survey was conducted in September 2023, a repeat of the 2022 survey. Data were collated and analysed in Excel.</p><p><strong>Results: </strong>In 2023, 48% (n=480) adults reported being sunburnt that summer. Younger adults were more likely than older adults to report sunburn (62% v 28% p<0.001). In assessing the \"SunSmart 5s\": 94% rated sunscreen, 88% rated shade, 84% rated hats, 71% rated long sleeves, and 70% rated sunglasses as important. Older adults were more likely than younger adults to rate each factor as important. A higher proportion reported each factor as important compared to 2022. Awareness of the campaign increased, 32% having heard of SunSmart, compared to 21% in 2022 (p<0.001). Awareness was higher in older adults (39% v 21% p<0.001), and in those who reported no sunburn (34% v 30% p=0.023).</p><p><strong>Conclusions: </strong>Awareness of SunSmart and perceived importance of the sun protection factors have improved since 2022, with perceived importance of the \"SunSmart 5s\" reasonably high. Reaching younger adults and improving their sun protection behaviours remain areas for progress.</p>","PeriodicalId":10324,"journal":{"name":"Clinical and Experimental Dermatology","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ced/llae450","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: SunSmart is the National Cancer Control Programme's annual skin cancer prevention awareness campaign.
Objectives: This study aimed to assess sun protection attitudes following the 2023 campaign, and compare findings to 2022.
Methods: An online survey was conducted in September 2023, a repeat of the 2022 survey. Data were collated and analysed in Excel.
Results: In 2023, 48% (n=480) adults reported being sunburnt that summer. Younger adults were more likely than older adults to report sunburn (62% v 28% p<0.001). In assessing the "SunSmart 5s": 94% rated sunscreen, 88% rated shade, 84% rated hats, 71% rated long sleeves, and 70% rated sunglasses as important. Older adults were more likely than younger adults to rate each factor as important. A higher proportion reported each factor as important compared to 2022. Awareness of the campaign increased, 32% having heard of SunSmart, compared to 21% in 2022 (p<0.001). Awareness was higher in older adults (39% v 21% p<0.001), and in those who reported no sunburn (34% v 30% p=0.023).
Conclusions: Awareness of SunSmart and perceived importance of the sun protection factors have improved since 2022, with perceived importance of the "SunSmart 5s" reasonably high. Reaching younger adults and improving their sun protection behaviours remain areas for progress.
期刊介绍:
Clinical and Experimental Dermatology (CED) is a unique provider of relevant and educational material for practising clinicians and dermatological researchers. We support continuing professional development (CPD) of dermatology specialists to advance the understanding, management and treatment of skin disease in order to improve patient outcomes.